677 results found | searching for "pharma"

First Previous 2 3 4 5 6 7 8 9 10 11 Next Last 
  • jameshebrew
  • The at-home self-testing kits market is projected to grow at a healthy pace, till 2035, claims Roots Analysis Driven by the various advantages offered by at-home self-testing kits and the growing awareness and adoption of such products post the onset of the COVID-19 outbreak, this market is abuzz with activity to develop kits for detection, diagnosis and screening purposes. London Roots Analysis has announced the addition of the “At home testing Kits Market , 2022–2035” report to its list of offerings. Owing to several advantages offered by at-home self-testing kits for diagnostics and screening purposes, industry stakeholders have undertaken numerous R&D initiatives focused on exploiting the use of such kits to provide healthcare at a fraction of a cost to the general public when compared to traditional clinics. Associated cost saving and privacy are main drivers of the growth of this domain over the coming decade. The ongoing innovations in this market are anticipated to bring a positive revolution in the healthcare domain. Given the continuous efforts being undertaken by industry players, the at-home self testing kits market is poised to witness healthy growth over the next decade. Key Market Insights Presently, more than 51% of the total at-home self-testing kit developers are based in North America This segment of the industry is dominated by the presence of companies that were established pre-2000 (37%), followed by firms established during 2000-2010 (32%). In addition, most of the players engaged in this domain are very small and small firms (less than 100 employees), representing close to 60% of the total kit developers. Over 500 at-home self testing kits are currently available in the market It is worth noting that most of the at home testing kits are currently being used for monitoring disorders (43%), followed by those employed for detection of conditions related to fertility and reproductive health (22%). Further, most of the kits are being developed to follow invasive route for the procurement of analyte (56%), followed by those being manufactured to utilize non-invasive methods for procuring analyte (43%). More than 1,130 grants have been awarded to support the ongoing research efforts in this domain Several non-profit organizations have extended financial support to aid the research related to at-home self-testing kits. It is worth mentioning that NIAID emerged as the most prominent non-profit organization, having awarded over 23% of grants for a period of 1-5 years, followed by NHLBI (12%). The demand for at-home self-testing kits is projected to grow at a rapid pace, in the foreseen future It is worth highlighting that the demand for HIV screening kits is expected to grow at a rate of 13%. Further, the highest demand for such products is expected to be driven by the Asia-Pacific region in 2035 (56%). The market is poised to be well distributed across different types of biofluids analyzed, till 2035 The current market is driven by kits developed for metabolic disorders (64%); this trend is unlikely to change in the foreseen future as well. Further, based on type of test format, strip-based tests are likely to have the maximum revenue generation potential (50%), by 2035. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/self-testing-kits-market/request-sample.html Key Questions Answered  Who are the leading players engaged in the manufacturing of at-home self-testing kits?  What is the most common diagnostic assays offered by at-home self-testing kit manufacturers?  What are the key regulatory frameworks for at-home self-testing kits across different regions?  What are the key factors influencing the price of at-home self-testing kits?  What is the likely valuation / net worth of companies engaged in this domain?  Which companies / institutes have received grants for research and development of at-home self-testing kits?  What is the current, global demand for at-home self-test kits?  How is the current and future market opportunity likely to be distributed across key market segments?  What is the current market scenario (in terms of existing competition and growth opportunities) across emerging and established market segments? The financial opportunity within the at-home self-testing kits market has been analyzed across the following segments:  Type of Test Format  Strip Format  Stick Format  Cassette Format  Others  Type of Biofluid Analyzed  Blood  Urine  Stool  Target Therapeutic Area  Metabolic Disorders  Fertility and Reproductive Health  Infectious Diseases  Oncological Disorders  Key Geographical Regions  North America  Europe  Asia-Pacific  Africa  South America The report includes profiles of key players (listed below); each profile features an overview of the company, details related to its at-home self-testing kits focused portfolio, recent developments, and an informed future outlook.  ACON Laboratories  AdvaCare Pharma USA  Apex Biotechnology  i-SENS  Oak Tree Health  Tai Doc Technology  VivaChek Laboratories For additional details, please visit https://www.rootsanalysis.com/reports/self-testing-kits-market.html You may also be interested in the following titles: 1. Viral Vaccine Cell Culture Media Market: Industry Trends and Global Forecasts, 2022-2035 2. Next Generation Sequencing (NGS) Kits Market: Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com [more]
  • latestmarketnews
  • The pharmaceutical sector, especially from Europe has been one among leading providers in healthcare and pharmaceutical products throughout the globe. In this sector, there has been good progress in recent years with respect to introducing revolutionary cures for life threatening health conditions along with community engagement initiatives or as part of philanthropy. Read More @ https://astra.grandviewresearch.com/european-pharmaceutical-industry-esg-outlook About Astra – ESG Solutions by Grand View Research Astra is the Environmental, Social, and Governance (ESG) arm of Grand View Research Inc. - a global market research publishing & management consulting firm. Astra offers comprehensive ESG thematic assessment & scores across diverse impact & socially responsible investment topics, including both public and private companies along with intuitive dashboards. Our ESG solutions are powered by robust fundamental & alternative information. Astra specializes in consulting services that equip corporates and the investment community with the in-depth ESG research and actionable insight they need to support their bottom lines and their values. We have supported our clients across diverse ESG consulting projects & advisory services, including climate strategies & assessment, ESG benchmarking, stakeholder engagement programs, active ownership, developing ESG investment strategies, ESG data services, build corporate sustainability reports. Astra team includes a pool of industry experts and ESG enthusiasts who possess extensive end-end ESG research and consulting experience at a global level. For more ESG Thematic reports, please visit@ https://astra.grandviewresearch.com/ [more]
  • jameshebrew
  • THE PHARMACEUTICAL INDUSTRY IS PRESENTLY EXPERIENCING A PROMINENT NEED FOR BIOAVAILABILITY ENHANCEMENT TECHNOLOGIES AND SERVICES Over the last couple of decades, the concept of bioavailability has garnered significant attention in the pharmaceutical industry. It is considered to be one of the most important pharmacokinetic properties of a drug. Bioavailability refers to the proportion of a drug that reaches systemic circulation unaltered, post dose administration. Additionally, it is a direct consequence of the absorption potential of an active pharmaceutical ingredient (API). The bioavailability of a drug is dependent on several factors, such as solubility, route of administration and metabolism of the drug post administration. The following figure provides different factors that have been reported to impact drug bioavailability either directly or indirectly. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/198/request-sample.html  Solubility: The solubility of a substance refers to its ability to dissolve in a solvent and form a homogeneous system. Drug solubility is considered to be one of the most important factors responsible for enabling a therapeutic intervention to be efficiently distributed via systemic circulation. It is worth highlighting that a drug’s solubility is directly proportional to its bioavailability and hence, is one of the primary parameters that is modified during bioavailability enhancement  Permeability: Permeability refers to the ability of a molecule to pass through biological membranes. Similar to solubility, drug permeability plays a key role in its absorption and systemic distribution. Membrane based efflux mechanisms and other structural barriers are the major biological elements responsible for poor permeability of drugs. Permeability of a drug is also proportional to its bioavailability; however, it is possible to improve this characteristic by modifying the physiochemical properties of the drug to render them more suitable for absorption across different types of biological membranes.  Molecule Size: Rate of absorption increases inversely with the size of a drug molecule. However, several studies have demonstrated that, absorption mechanisms vary significantly for different sizes of molecules. For instance, larger molecules get absorbed either by endocytosis or facilitated diffusion, whereas smaller molecules are absorbed via aqueous diffusion or through lipid channels.  Degree of Ionization: Degree of ionization has a direct impact on drug absorption. Higher degree of ionization of a drug molecule results in poor solubility. As a general rule, basic drugs get ionized in acidic medium and are therefore, poorly soluble in acidic medium. The same rule applies to acidic drugs in basic medium.  Formulation: The formulation process involves the addition of certain excipients, which are inactive substances that augment the properties of the drugs. Despite being inactive, these substances can influence drug bioavailability.  Concentration: According to Fick’s law of diffusion, higher drug concentration in a tissue microenvironment, leads to higher flux through the membrane, resulting in a high rate of absorption.  Dosage Forms: Drugs can be administered into the body via a number of routes, such as oral, transdermal, ocular and intramuscular. However, it is important to note that the mode of administration plays a very significant role in drug bioavailability. Several studies have demonstrated that only intravenous injections offer 100% drug availability in systemic circulation compared to any other route.  Physical Forms: The physical form of the drug (solid, liquid or inhalable powder) also affects its rate of absorption. It is worth highlighting that drugs get more absorbed in gaseous form followed by liquid and solid form respectively.  Chemical Nature: The chemical make-up of a drug is also an important determinant of its absorption potential and bioavailability. It has been observed that inorganic salts are more readily absorbed than organic compounds, when administered via the oral route. Further, given the rapid increase in the number of NCEs with low solubility and considering that this trend persists in the future as well, there is likely to be a surge in the demand for technologies that facilitate bioavailability enhancement. There are a number of technologies which are already available for improving drug bioavailability. Broadly these technologies can be distributed across three main categories, namely physical, chemical and biological approaches. However, as pharmacological interventions gradually become more complex and novel drug classes are introduced, further innovation may be required in the development of better bioavailability enhancement techniques / methods. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/bioavailability-enhancement-technologies-and-services/198.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. RNAi Market: Therapeutics and Technologies (Focus on siRNA, miRNA, shRNA and DNA) (3rd Edition): Industry Trends and Global Forecasts, 2022-2035 2. Global Therapeutic Vaccines Market: Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com [more]
  • passavant7
  • Passavant Memorial Homes | Website: https://triblive.com/local/regional/passavant-memorial-homes-boosts-pay-during-special-week/ | Address: 100 Passavant Way, Pittsburgh, PA 15238 | Phone: 412-820-1010 | Passavant Memorial Homes is a non-profit organization that was founded in 1931. This non-profit’s mission aims to empower people who have autism, intellectual disabilities, and behavioral health needs by providing them a community they can thrive in. Some services provided by Passavant Memorial Homes include dental, pharmacy, day programs, and so much more. The current community has over 250 people living on property either independently or with their family depending on what their needs are. In addition to living on property, Passavant Memorial Homes can provide companion services where an individual is sent to provide care and assistance to those 18 and older. If Passavant Memorial Homes can help you or a family member, visit their website to learn more information. #Non-profit #Passavant Memorial Homes | Facebook: https://www.facebook.com/PassavantMemorialHomes
  • jameshebrew
  • The SARM1 targeting therapeutics market is projected to grow at a CAGR of 102.1%, during the period 2033-2040, claims Roots Analysis SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share. Roots Analysis has announced the addition of “SARM1 Inhibitors Therapeutics Market , 2022 – 2040” report to its list of offerings. Presently, several industry and non-industry stakeholders are evaluating SARM1 inhibitors as potential therapeutic agents for the treatment of neurological disorders across various preclinical studies and early stages of clinical development, worldwide. With the ongoing pace of innovation in this field, increasing R&D activity and promising pre-clinical data, several promising leads are anticipated to be commercially launched over the coming decade and SARM1 targeting therapeutics market is anticipated to witness substantial growth in the mid to long-term. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/sarm1-inhibitors-market/request-sample.html Key Market Insights Presently, several SARM1 targeting therapy candidates are being developed by various industry players About 65% of the pipeline candidates are currently being evaluated in the preclinical stages of development, followed by those currently in the discovery stage (35%). Further, it is worth mentioning that close to 85% of the SARM1 inhibitors are small molecules. Currently, a number of companies claim to be engaged in the development of SARM1 inhibitors The SARM1 inhibitors market is dominated by the presence of large companies (81%), followed by small players (19%). In addition, around 20% of the players were established post-2010. 120+ articles related to SARM1 inhibitors have been published between 2011 and 2022 Majority (81%) of the articles published in this domain were research papers, followed by review papers (12%). It is important to note that more than 70% of the total number of articles were published post-2018. Over 30 grants have been awarded for research related to SARM1 inhibitors, since 2014 Close to 40% of the total amount was awarded under the R01 mechanism (which supports research projects). Further, genetics and neurology emerged as the key research departments, having received 34% of the total grants, each. 70+ patents related to SARM1 targeting therapeutics have been filed / granted till 2022 Over the years, the number of patents filed for SARM1 inhibitors has increased gradually; majority of the patents have been filed / granted in 2021. Most of the patents in this domain are patent applications (96%), followed by granted patents (3%). North America is anticipated to capture more than 65% share of the market, by 2040 By 2040, the market revenues are likely to be driven by the sales of small molecules (95%) being developed as SARM1 inhibitors. Further, sales of therapeutics targeting multiple sclerosis are likely to contribute to a majority share (~40%) of revenues, in the long term. For additional details, please visit https://www.rootsanalysis.com/reports/sarm1-inhibitors-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. RNAi Market: Therapeutics and Technologies (Focus on siRNA, miRNA, shRNA and DNA) (3rd Edition): Industry Trends and Global Forecasts, 2022-2035 2. Global Therapeutic Vaccines Market: Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com [more]
  • asinfovision1
  • Medical Education isn't restricted to the data that is given inside the homeroom rather it remains closely connected with the experience that goes with medical profession. Medical education then again is an extreme and extended process. From the staggering research facility practices to the ceaseless pharmacology, medical students target accomplishing their objective to give vital medical care to every one individuals on the planet. Medicine is one of the most famous vocation ways across the globe. Study MBBS Abroad is nearly more affordable than that in India. However the educational expenses can be inside the reasonable reach, students should likewise search for different costs prior to choosing to move to another country for higher studies. For more details visit at our website: https://www.theeducationabroad.com/blog/striving-for-a-better-medical-education-at-an-affordable-tuition-fee
  • yraclark
  • How do I Qualify to Own an Emotional Support Animal in California? That's simple! To qualify for all of the benefits of emotional support animal protection, a California pet owner only needs to obtain an ESA letter from a licensed medical professional in the state. Most doctors are happy to help their patients with this because the companionship of dogs, cats, and other animals is an excellent non-pharmaceutical treatment for many conditions. Read more: https://fastesaletter.com/emotional-support-animal-letter-california/
  • jameshebrew
  • CAR-T CELL THERAPIES: ADDRESSING KEY UNMET NEEDS ACROSS VARIOUS ONCOLOGICAL INDICATIONS Amidst the active initiatives undertaken to develop more targeted anti-cancer therapies, CAR-T therapies have emerged as a promising option, given their ability to eradicate tumor cells from the body with minimal treatment-related side effects. Further, CAR-T cell therapy, a relatively recent addition to the gamut of anticancer interventions, has demonstrated significant promise. Overall, this highly specific and promising form of CAR-T cell therapy treatment, which harnesses the versatile effector machinery of the human immune system, has revolutionized cancer treatment, globally. Given the consistent increase in number of cell therapies being developed and launched, this upcoming therapeutic segment is on its way to becoming one of the highest valued markets within the biopharmaceutical industry. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/269/request-sample.html At present, more than 5 CAR-T therapies have been approved for several hematological malignancies, including KYMRIAH® (Novartis), YESCARTA® (Gilead Sciences), TECARTUS™ (Gilead Sciences), Breyanzi® (Bristol Myers Squibb), Abecma™ (Bristol Myers Squibb) and CARVYKTI™ (Janssen Biotech / Legend Biotech). In fact, more than 170 companies are engaged in the development of over 970 early and late-stage CAR-T therapies, worldwide. Moreover, several promising leads are anticipated to be commercially launched over the coming decade, following which the market is projected to grow at a substantial pace. Over 6,500 patents related to CAR-T cell therapies have been recently filed / granted, demonstrating the continued innovation in this domain. In addition, more than 260 collaborations have been inked between several industry / academic stakeholders in order to advance the development of various pipeline candidates. To fund product development initiatives, capital investments worth more than USD 24 billion have been made by various private and public sector investors, in the last few years. Driven by the ongoing pace of innovation in this field, sufficient financial support from investors and encouraging clinical trial results, the CAR-T cell therapy market is likely to witness significant growth in the foreseen future. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com [more]
  • arif12
  • Single use Bioreactors Market Research Size, Share, Growth, Industry Forecast 2022-2029 The Single use Bioreactors Market projected at USD 2.9 billion in 2021 and is expanding at a CAGR of 18.7% during the period 2022-2029, and is anticipated to reach USD 11.4 billion in 2029. The factors driving the growth of Single use Bioreactors Market includes rising demand for pharmaceutical products around the world, expansion of the biologics industry, growing focus by companies on developing effective vaccines and increasing acceptance for single use bioreactors amongst small size organizations and start-ups. More Info, Click to Access Complete Rep - https://www.promorapid.com/read-blog/289485_single-use-bioreactors-market-research-size-share-growth-industry-forecast-2022.html [more]
  • KaiserPermanenteLogi
  • Here Are Member Benefits for Kaiser Permanente Login In addition to pharmacy, medical, dental, and vision coverage, Kaiser Permanente also offers other benefits to its members. Depending on your plan and where you stay, you might be suitable for the following: Silver & Fit: This program helps the members of Kaiser Permanente with a Medicare advantage HMO plan stay alive. Choose Healthily: Kaiser Members get discounts on gym membership, fitness gear, and some complementary therapies such as massage and acupuncture. Wellness Coaching: Get phone support for reducing stress and losing weight. Smoking-Cessation Programs: The depart for life program is an exclusive phone-based program with an online tool. Transportation to Medical Appointments: The members of Kaiser Permanente login get free rides to health appointments if registered in a Kaiser Medicare plan. #kaisersignin #kaiserpermanentelogin Visit here:- https://kaisorpermanante-logi.com/
First Previous 2 3 4 5 6 7 8 9 10 11 Next Last